Covalon Technologies (CVALF) Stock Price, News & Analysis

Company Overview

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian life sciences company specializing in the development and commercialization of infection prevention and wound care technologies. The company’s core competencies lie in advanced antimicrobial coatings, biocompatible wound dressings and medical device technologies designed to reduce the risk of infection in surgical and acute care settings. Covalon’s product pipeline includes implantable antimicrobial coatings for orthopaedic and reconstructive devices, transparent wound care dressings that deliver targeted antimicrobial agents, and advanced catheter coatings engineered to combat central line–associated bloodstream infections.

Founded in 2001 and headquartered in Vancouver, British Columbia, Covalon has expanded its global footprint with commercial operations across North America, Europe and select markets in Asia. The company leverages a network of distributors and strategic partnerships to bring its proprietary technologies into hospitals, clinics and specialty care centers. Its manufacturing facilities conform to ISO 13485 standards, and its regulatory clearances span Health Canada, the U.S. Food and Drug Administration and the European CE marking process.

Under the guidance of an executive team with extensive expertise in biomedical engineering, regulatory affairs and medical device commercialization, Covalon continues to advance its research programs and pursue opportunities in emerging wound care markets. The leadership’s focus on strategic collaborations and intellectual property development positions the company to address unmet clinical needs and to drive long-term growth in infection prevention and wound management sectors.

Key Stats

• Today's Range: $1.93 to $1.99
• 50-Day Range: $1.66 to $2.05
• 52-Week Range: $1.46 to $3.08
• Volume: 14,000 shs
• Average Volume: 3,537 shs
• Market Capitalization: $54.20 million
• P/E Ratio: 21.96
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CVALF Stock Analysis - Frequently Asked Questions

How have CVALF shares performed this year?

Covalon Technologies' stock was trading at $2.24 at the beginning of the year. Since then, CVALF stock has decreased by 11.8% and is now trading at $1.9765.

How were Covalon Technologies' earnings last quarter?

Covalon Technologies Ltd. (OTCMKTS:CVALF) announced its quarterly earnings data on Wednesday, May, 28th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.01. The firm earned $5.27 million during the quarter, compared to analysts' expectations of $7.67 million. Covalon Technologies had a net margin of 10.95% and a trailing twelve-month return on equity of 13.40%.

How do I buy shares of Covalon Technologies?

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/28/2025
• Today: 7/11/2025
• Next Earnings (Estimated): 8/19/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CVALF
• CIK: N/A
• Web: www.covalon.com
• Phone: (905) 568-8400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.09
• Trailing P/E Ratio: 21.96
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.96 million
• Net Margins: 10.95%
• Pretax Margin: 10.93%
• Return on Equity: 13.40%
• Return on Assets: 11.59%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.39
• Quick Ratio: 6.09

Sales & Book Value

• Annual Sales: $22.91 million
• Price / Sales: 2.37
• Cash Flow: $0.10 per share
• Price / Cash Flow: 18.86
• Book Value: $0.74 per share
• Price / Book: 2.67

Miscellaneous

• Outstanding Shares: 27,420,000
• Free Float: N/A
• Market Cap: $54.20 million
• Optionable: Not Optionable
• Beta: 0.54